COMBSecretomics: A pragmatic methodological framework for higher-order drug combination analysis using secretomics

• Published in: PloS one 2020-05, Vol.15 (5), p.e0232989-e0232989
• Main Authors: Chantzi, Efthymia, Neidlin, Michael, Macheras, George A, Alexopoulos, Leonidas G, Gustafsson, Mats G
• Format: Article
• Language: English
• Subjects: Analytical chemistry; Arthritis; Bioinformatics; Bioinformatik; Biology and Life Sciences; Cartilage; Cell interactions; Cell signaling; Cells (Biology); Cluster analysis; Clustering; Combination drug therapy; Data mining; Development projects; Disease; Diseases; Drug discovery; Drug therapy; Drugs; Electrical engineering; Engineering and Technology; Experiments; Farmakologi; generalized highest single agent; higher-order drug combination analysis; Laboratories; Mechanical engineering; Medical research; Medical treatment; Medicine and Health Sciences; Methods; multi-input multi-output cell-cell communication; Novels; Outliers (statistics); Pharmacological research; Pharmacology; Proteins; Proteomics; Quality control; resampling; Research and Analysis Methods; Secretome; secretomics; Social Sciences; Statistical analysis; top-down hierarchical clustering
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0232989

Multi drug treatments are increasingly used in the clinic to combat complex and co-occurring diseases. However, most drug combination discovery efforts today are mainly focused on anticancer therapy and rarely examine the potential of using more than two drugs simultaneously. Moreover, there is currently no reported methodology for performing second- and higher-order drug combination analysis of secretomic patterns, meaning protein concentration profiles released by the cells. Here, we introduce COMBSecretomics (https://github.com/EffieChantzi/COMBSecretomics.git), the first pragmatic methodological framework designed to search exhaustively for second- and higher-order mixtures of candidate treatments that can modify, or even reverse malfunctioning secretomic patterns of human cells. This framework comes with two novel model-free combination analysis methods; a tailor-made generalization of the highest single agent principle and a data mining approach based on top-down hierarchical clustering. Quality control procedures to eliminate outliers and non-parametric statistics to quantify uncertainty in the results obtained are also included. COMBSecretomics is based on a standardized reproducible format and could be employed with any experimental platform that provides the required protein release data. Its practical use and functionality are demonstrated by means of a proof-of-principle pharmacological study related to cartilage degradation. COMBSecretomics is the first methodological framework reported to enable secretome-related second- and higher-order drug combination analysis. It could be used in drug discovery and development projects, clinical practice, as well as basic biological understanding of the largely unexplored changes in cell-cell communication that occurs due to disease and/or associated pharmacological treatment conditions.